SCHEMBL17481602

SCHEMBL17481602

Cc1ccc(NC=C2C(=O)NN=C2c2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.55
LMNA P02545 5/20 0.55
KDR P35968 2/20 0.50
MAPT P10636 7/20 0.45
KMT2A Q03164 5/20 0.45
RAB9A P51151 5/20 0.45
MEN1 O00255 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
NPC1 O15118 3/20 0.45
GAA P10253 3/20 0.45
NPSR1 Q6W5P4 3/20 0.36
PKM P14618 2/20 0.36
S1PR4 O95977 1/20 0.36
S1PR1 P21453 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HTT P42858 1/20 0.35
CCR6 P51684 1/20 0.35
KDM4E B2RXH2 2/20 0.34
PLIN1 O60240 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17481601 0.90 ALDH1A1 (0.57) ALDH1A1LMNAKDRMAPTKMT2A
SCHEMBL23192514 0.90 ALDH1A1 (0.57) ALDH1A1LMNAKDRMAPTKMT2A
SCHEMBL17481600 0.86 ALDH1A1 (0.51) ALDH1A1LMNAKDRMAPTKMT2A
SCHEMBL4865450 0.75 ALDH1A1 (0.42) ALDH1A1LMNAKDRMAPTKMT2A
SCHEMBL4865457 0.75 ALDH1A1 (0.42) ALDH1A1LMNAKDRMAPTKMT2A
SCHEMBL4999350 0.70 ALDH1A1 (0.58) ALDH1A1LMNAKDRMAPTKMT2A
SCHEMBL11887930 0.70 ALDH1A1 (0.58) ALDH1A1LMNAKDRMAPTKMT2A
SCHEMBL12585064 0.68 MAPT (0.50) ALDH1A1LMNAMAPTKMT2ARAB9A
SCHEMBL4990942 0.66 ALDH1A1 (0.52) ALDH1A1LMNAKDRMAPTKMT2A
SCHEMBL3575951 0.66 ALDH1A1 (0.52) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963452-B2 Methods, compounds, and compositions for inhibition of ROS AUGUSTA PHARMACEUTICALS INC. (US) 2018-05-08 US disclosed
US-20160031890-A1 NOVEL METHODS, COMPOUNDS, AND COMPOSITIONS FOR INHIBITION OF ROS GRUENEBERG, Dorre A. 2016-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160031890-A1 NOVEL METHODS, COMPOUNDS, AND COMPOSITIONS FOR INHIBITION OF ROS ROS1, NOX4, NOX1 ALDH1A1 1362/4885LMNA 3870/4885KDR 1390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.